|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 65.93 USD | -0.80% |
|
+6.34% | +109.04% |
| 07-13 | MBX Biosciences Appoints Steve Hoerter as CEO; Kent Hawryluk Steps Down | MT |
| 07-13 | MBX Biosciences, Inc. Announces CEO Changes, Effective July 13, 2026 | CI |
| Market Cap | 3.14B 2.73B 2.54B 2.33B 4.4B 300B 4.47B 29.93B 11.75B 149B 11.79B 11.53B 500B | P/E 2026 * |
-23.6x | P/E 2027 * | -17.9x |
|---|---|---|---|---|---|
| Enterprise Value | 2.59B 2.26B 2.1B 1.93B 3.64B 248B 3.7B 24.75B 9.71B 123B 9.74B 9.53B 413B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
97.3% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: MBX Biosciences, Inc.
| 1 day | -0.80% | ||
| 1 week | +6.34% | ||
| 1 month | +17.90% | ||
| 3 months | +121.39% | ||
| 6 months | +78.91% | ||
| Current year | +109.04% |
| 1 week | 58.78 |  | 69.4 |
| 1 month | 52.51 | | 69.4 |
| Current year | 26.14 | | 69.4 |
| 1 year | 9.63 | | 69.4 |
| 3 years | 4.81 | | 69.4 |
| 5 years | 4.81 | | 69.4 |
| 10 years | 4.81 | | 69.4 |
| Manager | Title | Age | Since |
|---|---|---|---|
Steven Hoerter
CEO | Chief Executive Officer | 55 | 2026-07-12 |
John Smither
DFI | Director of Finance/CFO | 73 | 2026-02-28 |
Andreas Moraitis
CTO | Chief Tech/Sci/R&D Officer | - | 2025-06-22 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 66 | 2020-06-30 | |
Patrick Heron
BRD | Director/Board Member | 55 | 2020-06-30 |
Ora Pescovitz
BRD | Director/Board Member | 69 | 2022-04-04 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 2/26/26 | Fiscal year | Founder | 57,536 | 0.1287% | ||
| 2/2/26 | Free | Chief Financial Officer | 85,000 | 0.1902% | ||
| 2/2/26 | Free | Chief Technology Officer | 85,000 | 0.1902% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.80% | +6.34% | +379.49% | - | 3.14B | |
| -1.40% | +2.59% | -1.71% | +11.28% | 48.53B | |
| -2.41% | -0.90% | +411.96% | +495.33% | 39.87B | |
| -1.16% | +12.96% | +28.81% | +7.25% | 38.68B | |
| -1.88% | -3.03% | +5.69% | +53.00% | 35.13B | |
| -1.74% | +5.12% | +14.44% | +41.77% | 29.79B | |
| -0.21% | -4.04% | +36.40% | +125.75% | 16.11B | |
| -2.85% | -3.92% | - | - | 16.08B | |
| -0.64% | +2.65% | +3.40% | +13.11% | 13.61B | |
| -1.19% | -1.32% | -1.73% | -34.37% | 12.62B | |
| Average | -1.43% | +1.58% | +97.42% | +89.14% | 25.36B | |
| Weighted average by Cap. | -1.59% | +2.09% | +83.74% | +108.61% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | -134M -116M -108M -99.18M -187M -12.74B -190M -1.27B -500M -6.34B -501M -490M -21.28B | -195M -170M -158M -145M -274M -18.62B -278M -1.86B -730M -9.27B -733M -717M -31.09B |
| Net Debt | -543M -472M -440M -404M -762M -51.88B -774M -5.18B -2.03B -25.83B -2.04B -2B -86.6B | -507M -441M -410M -377M -711M -48.4B -722M -4.84B -1.9B -24.1B -1.9B -1.86B -80.8B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-31 | US$65.93 | -0.80% | 566,278 |
| 26-07-30 | US$66.46 | +3.91% | 548,134 |
| 26-07-29 | US$63.96 | +6.49% | 564,724 |
| 26-07-28 | US$60.06 | -2.02% | 625,724 |
| 26-07-27 | US$61.30 | -1.13% | 304,265 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- MBX Stock
Select your edition
All financial news and data tailored to specific country editions
